Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with azithromycin and other drugs reduced COVID-19 symptoms and complications.

Experts recommend starting systemic treatment for alopecia areata when the condition is severe or causes significant distress.

Adipose-derived stem cells may help with hair loss, but more research is needed.

New findings suggest certain genes and microRNAs are crucial for wound healing, and innovative technologies like smart bandages and apps show promise in improving treatment.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Alopecia areata greatly harms quality of life, causing emotional and social issues.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

Ritlecitinib improves emotional well-being and activity levels in alopecia areata patients.

The criteria help doctors diagnose and treat alopecia areata more effectively.

Activated PRP effectively increases hair density and reduces hair loss in alopecia.

Contact immunotherapy can improve hair regrowth in alopecia areata patients.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

Non-Kuwaiti COVID-19 patients had worse health outcomes than Kuwaitis, likely due to poorer socioeconomic conditions.

People with moderate hair loss from Alopecia Areata feel more impacted than those with no or almost complete hair loss, and are more likely to seek treatment.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Alopecia Areata severely impacts mental health, causing anxiety and depression, affecting quality of life.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Young adults who had liver disease as children often experience significant health problems and frequently need transplants.

The combined therapy improved symptoms in PCOS patients.

Patients should discuss complementary medicine use with doctors to improve health outcomes.

The EQ-5D-5L tool may not accurately measure the impact of alopecia areata on patients' lives.

Tailored combination therapy improves non-scarring alopecia outcomes.

Palbociclib generally maintains or improves quality of life in advanced breast cancer patients.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Understanding gender differences and individual patient characteristics is essential for optimal cosmetic surgery outcomes.

Platelet-rich plasma treatment for hair loss may improve patients' quality of life.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

The Polish Skindex-29 is a reliable and valid questionnaire for assessing the quality of life in Polish dermatology patients.